D. E. Shaw & Co., Inc.
- SEC CIK
- 0001009207
- Latest filing
- Aug 14, 2026
LAB holding history
Standard Biotools Inc. in every 13F filed by D. E. Shaw & Co., Inc., including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
LAB overviewAll 13F holders of LABFull Q2 2026 holdings
- Shares (Q2 2026)
- 2,818,026
- Value
- $2.32M
- % of portfolio
- <0.1%
- Quarters held
- 13
- Since Q1 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2026 | 2,818,026 | $2.32M | <0.1% | +2,618,942+1,315.5% | Added | Holders |
| Q1 2026 | 199,084 | $183.0K | <0.1% | +199,084 | New | Holders |
| Q4 2023 | 0 | $0 | 0.0% | −144,598−100.0% | Sold out | Holders |
| Q3 2023 | 144,598 | $419.3K | <0.1% | −199,099−57.9% | Reduced | Holders |
| Q2 2023 | 343,697 | $663.3K | <0.1% | −236,806−40.8% | Reduced | Holders |
| Q1 2023 | 580,503 | $1.13M | <0.1% | −206,711−26.3% | Reduced | Holders |
| Q4 2022 | 787,214 | $921.0K | <0.1% | −19,936−2.5% | Reduced | Holders |
| Q3 2022 | 807,150 | $888.0K | <0.1% | −81,886−9.2% | Reduced | Holders |
| Q2 2022 | 889,036 | $1.42M | <0.1% | +59,007+7.1% | Added | Holders |
| Q1 2022 | 830,029 | $2.98M | <0.1% | −61,606−6.9% | Reduced | Holders |
| Q4 2021 | 891,635 | $3.50M | <0.1% | +102,428+13.0% | Added | Holders |
| Q3 2021 | 789,207 | $5.20M | <0.1% | +78,477+11.0% | Added | Holders |
| Q2 2021 | 710,730 | $4.38M | <0.1% | +172,456+32.0% | Added | Holders |
| Q1 2021 | 538,274 | $2.43M | <0.1% | – | – | Holders |
Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.